Theme: Exploring the advanced novelties of Gastroenterology and Urology
Asian Gastro 2020
We invite all the participants to attend our Webinar on 22nd World Congress on Advances in Gastroenterology and Urology (Asian Gastro 2020) to be held on August 17-18, 202 at 10:00 am (London Time Zone).
Asian Gastro 2020 is tied in with giving a bright and educated field for the individuals in the field of Gastroenterology and Urology. We provide a perfect stage to share the knowledge and experiences and empower people endeavours to fight against the worldwide risk.
Asian Gastro 2020 offers a cutting-edge program of renowned international speakers, specialist concurrent sessions, short paper and poster presentations attracting experts in all the various fields of Gastroenterology and Urology. This conference has been carefully designed to meet the unique educational needs of physicians and medical practitioners. In addition to cutting-edge presentations and debates, this year agenda provides you with an opportunity to participate in organize a workshop.
- Urological Nurses
- Radiation Oncologists
- Medical Oncologists
- Medical Practitioners, Professors
- Clinical researchers & Scientists
- Interventional Radiologists
- General Practitioners
- Reconstructive Surgeons
- Residents and Trainees
- Deans, Students & Technicians
- Health care Organizations
- Medial Health Associations
- Researchers & Scholars
- Public Health Professional
- Allied Health Professionals
Who Should Attend?
- Urology residents
- Pediatric urology fellows
- Surgery residents
- Pediatric surgery residents
- Pediatric Urologists
- Pediatric Surgeons
- Physician Assistants
Why to attend?
To meet and greet the Gastroenterology Professionals from all over the world, focusing on Gastrointestinal disorders and its advances, this is the golden opportunity to reach the largest gathering of all the professionals from Gastroenterology department to conduct presentations, Spread information, to acknowledge various researches in the field, meeting with upcoming scientists, to interact with experienced professionals for better research technics and make a mark with new innovations in the field of Digestive Disorders and Gastroenterology diseases. To experience the Global esteemed Speakers, to acknowledge most recent techniques, developments, discoveries and latest updates in the field of Gastroenterology. Digestive Disorders and Gastroenterology is the hallmarks of this Webinar.
22nd World Congress on Advances in Gastroenterology and Urology which is going to take place during August 17-18, 2020 at the Webinar is the best platform to explore more all the aspects of Gastroenterology including the research and market analysis. So don’t miss the opportunity.
Opportunities for Conference Attendees
For Universities, Associations & Societies:
For Students & Research Scholars:
- Poster Competition (Winner will get Best Poster Award)
- Young Researcher Forum (YRF Award to the best presenter)
- Student Attendee
- Group registrations
For Business Delegates:
- Speaker Presentations
- Symposium hosting
- Book Launch event
- Networking opportunities
- Audience participation
- Exhibitor and Vendor booths
- Sponsorships opportunities
- Product launch
- Workshop organizing
- Scientific Partnering
- Marketing and Networking with clients
Track 1: Fundamentals & Advancements in Gastroenterology
Gastroenterology is the field of drugs devoted specifically to treatment for the gastrointestinal system. The alimentary canal may be a tube-like structure which extends from the mouth to the anus. Histologically the gut comprises of four main layers: the mucosa, which comprises epithelial cells (enterocytes, endocrine cells and others), the lamina propria and the muscular is mucosae; the submucosal; two muscle layers, an inner thick circular layer and an outer thin longitudinal layer; and a serosal layer.
Track 2: Gastrointestinal Disorders and Symptoms
Gastrointestinal disorders include conditions such as irritable bowel syndrome, constipation, haemorrhoids, anal fissures, anal fistulas, perianal abscesses, perianal infections, diverticular diseases, colitis, colon polyps and cancer. Many of these can be prevented or minimized by, practicing good bowel habits, maintaining healthy lifestyle and submitting to cancer screening.
Track 3: Gastroenteritis
Gastroenteritis, commonly referred to as the stomach flu, include the combination of diarrhoea, vomiting, and abdominal pain. Fever, lack of energy, and dehydration may also occur. This typically lasts less than two weeks. Depending on the cause, viral gastroenteritis symptoms may appear within one to three days after you're infected and can range from mild to severe Gastroenteritis can be due to infections by viruses, bacteria, parasites, and fungus.
Track 4: Treatment Advances in Digestive Disorders
The major cause of peptic ulcer disease and gastric cancer peptic ulcer disease and gastric cancer is Helicobacter pylori (H. pylori). No signs and symptoms are found with H. pylori infection in most of the people. Diagnosis can be done using blood test, breath test, stool test, scope test. Proton pump inhibitors, Histamine (H-2) blockers, Bismuth subsalicylate are used for the treatment.
Track 5: Gastric cancer
Gastric cancer is one of the most common human cancer types. In overall, cancer initiates when an error (mutation) occurs in a cell's DNA. The mutation grounds the cell to raise and split at a rapid rate and to continue living when a normal cell would die. The accumulating cancerous cells form a tumour that can invade nearby structures. And cancer cells can breakdown off from the tumour to feast throughout the body.
Track 6: Inherited GI cancer syndromes
Gastrointestinal disease is one of the real reasons for death around the world. Inherited gastrointestinal malignancy disorders comprise around 5-10% everything being equal. Around 20-25% of undiscovered cases have a conceivable genetic segment, which isn't yet settled. Over the most recent couple of decades, the development in genomics has prompted the revelation of various malignant growth inclination qualities in gastrointestinal disease.
Track 7: Treatment Advances in GI Cancers
Gastrointestinal tumours are a gathering of profoundly forceful malignancies, and novel restorative methodologies with higher clinical viability are by and large effectively looked for. 'Immunotherapy' is currently developing as one such encouraging procedure for the treatment of these tumours. This article quickly audits the ongoing advances that use focusing of resistant checkpoint pathways, in the administration of gastrointestinal malignancies.
Track 8: Innovative Gastroesophageal Reflux Disease Treatment
GERD today is ordinarily treated with drugs, for example, histamine receptor opponents (H2 blockers), - Pepcid, Tagamet and Zantac - and with proton siphon inhibitors (PPIs) - Nexium, Prilosec and Protonic. Shockingly, these drugs can lose their viability after some time. More significantly, they don't treat the fundamental main drivers of indigestion.
Track 9: Liver Function & Liver Health
The liver is body’s largest internal organ on the right-hand side of the belly. Liver is an essential organ that has many functions in the human body and including making proteins and blood clotting factors, manufacturing triglycerides and cholesterol, glycogen synthesis and bile production. The liver also filters the blood coming from the digestive tract and detoxifies the chemicals and metabolizes the vitamins, proteins, fats, carbohydrates and drugs and it secrets the bile that ends up back in the intestine.
- Blood detoxification and Purification
- Bile production and Excretion
- Metabolism of Fats, Proteins and Carbohydrates
- Synthesis of Plasma Proteins
Track 10: Hepatitis and its Types
An inflammatory condition of the liver is Hepatitis. It’s commonly caused by a viral infection; there are other possible causes of hepatitis. These include auto immune hepatitis that occurs as a secondary result of medications, drugs, toxins, and alcohol. When your body makes antibodies against your liver tissue Autoimmune hepatitis occurs. Viral infections of the liver that are classified include hepatitis A, B, C, D, and E.
Track 11: Effect of Supplements in Gastro and Hepato Disorders
A huge measure of information from research was distributed over the previous decades concerning the jobs of various nutrients in different gastrointestinal ailments. For example, most nutrients demonstrated an opposite association with the danger of colorectal carcinoma just as different malignancies like gastric and oesophageal disease in observational preliminaries, anyway interventional preliminaries neglected to demonstrate a reasonable gainful preventive job. Then again, increasingly strong proof was gotten from excellent investigations for a job of specific nutrients in explicit elements
Track 12: Pancreatic disease
The pancreas is a large gland behind the stomach and next to the small intestine which produces juices that help break down food and hormones and help control blood sugar levels. The pancreas does two main things:
- It releases powerful digestive enzymes into the small intestine to aid the digestion of food.
- It releases the hormones insulin and glucagon into the bloodstream. These hormones help the body control how it uses food for energy.
Track 13: Pancreatic cancer
It starts when cells in the pancreas start to grow out of control. Pancreatic cancer initiates when abnormal cells in the pancreas grow and divide out of mechanism and form a tumour. Organs, similar the pancreas, are made up of cells. Usually, cells split to form new cells as the body desires them. When cells get old, they die, and new cells take their place. Cancers that cultivate within the pancreas fall into two chief categories:
- Cancers of the endocrine pancreas are called "islet cell" or "pancreatic neuroendocrine tumours or PNETs"
- Cancers of the exocrine pancreas (the part that makes enzymes)
Track 14: Hepato-Pancreatic-Biliary Infectious Diseases
Hepato-pancreato-biliary disease refers to any condition that affects the liver, pancreas, gallbladder, and the bile ducts. These diseases commonly share some tell-tale signs or symptoms, such as jaundice, darker urine colour, and lighter stool colour. While some have genetic or hereditary causes, most are due to chronic damage to the tissues of the organs involved. These conditions are treated and managed by hepatologists, hepato-pancreato-biliary oncologists, and transplant specialists. There are several treatment options available for patients suffering from any liver, pancreatic, or biliary disease.
Track 15: Urology
Urology is a part of health care that deals with diseases of the male and female urinary tract (kidneys, ureters, bladder and urethra). It also deals with the male organs that can make babies (penis, testes, scrotum, prostate, etc.) The scope of urology is big, and the American Urological Association has named seven subspecialty parts:
- Pediatric Urology (children's urology)
- Urologic Oncology (urologic cancers)
- Renal (kidney) Transplant
- Male Infertility
- Calculi (urinary tract stones)
- Female Urology
- Neuro-urology (nervous system control of genitourinary organs
Track 16: Urinary Tract Infection
A urinary tract infection naturally occurs when bacteria pass in the urinary tract through the urethra and initiate to growth in the bladder. Although the urinary system is designed to keep out such microscopic interlopers, these defences sometimes fail. When that occurs, bacteria may take hold and grow into a full-blown infection in the urinary tract. Urinary tract infections (UTIs) are very predominantly in women, babies and older people. Around one in two women and one in 20 men will get a UTI in their lifetime.
Track 17: Urinary Retention
This session is devoted to discussing a condition of the bladder, because of which one is unable to start urination, or if started is unable to completely empty the bladder. Urinary retention is more common in men than women. Treatment differs for acute and chronic urinary retention. Some of the most common causes of non-obstructive urinary retention are: Stroke, Vaginal childbirth, Pelvic injury or trauma, impaired muscle or nerve function due to medication or anaesthesia, accidents that injure the brain or spinal cord. Obstructive retention may result from: Cancer, Kidney or bladder stones, Enlarged prostate (BPH) in men.
Track 18: Urinary Tract Imaging
A kidney stone or a tumour may block urine flow and cause pain. Under such times, urinary tract imaging helps the doctors to diagnose the disease. Here we are to discuss the imaging of the two kidneys, two ureters, a bladder, and a urethra which comprises of the Urinary Tract. Interstitial cystitis (IC) may be treated with lifestyle changes, bladder training, physical therapy, medicines, bladder hydro distension, bladder instillation, surgery, or a combination of these treatments
Track 19: Urology Robotic Surgery
The urologists bid minimally invasive robotic-assisted surgery for several urological diseases including prostate cancer, kidney obstruction, and bladder reconstruction. Robotic-assisted surgery provides parallel benefits in children with a short period of time and improved therapies. Robotic surgery enables urological surgeons to perform more precise operation than conventional surgery.
Track 20: Kidney Stones
Excessive minerals accumulate to form stones in the inner lining of the Kidney which are known as Kidney stones. They usually consist of calcium oxalate but may be composed of several other compounds. Kidney stones can grow to the size of a golf ball while maintaining a sharp, crystalline structure. The stones may be small and pass unnoticed through the urinary tract, but they can also cause extreme pain as they leave the body. Kidney stones are very commonly found in Americans. Minimally invasive treatments are found effective for Kidney stones. All the factors can be discussed in this session.
Track 21: Kidney Cancer
Kidney cancer is a disease that starts in the kidneys. Renal cell cancer (renal cell carcinoma or RCC) is a disease that occurs when certain kidney cells become malignant or cancerous and grow out of control, forming a tumour in one or both kidneys. The renal cancer cells may spread to other areas of the body. The incidence of urinary organ cancer appears to be increasing. Smoking and misuse of certain analgesics will influence the danger of nephritic cell cancer or nephritic pathological process. Signs of renal cell cancer seize blood within the faces and lump within the abdomen.
Track 22: Kidney Transplantation
Kidney transplantation may be a surgery to put a healthy urinary organ from a living donor into someone whose kidneys now not perform properly. A urinary organ transplant is normally the treatment of renal disorder. A urinary organ transplant will treat chronic malady or renal disorder or End-stage urinary organ disease to assist you are feeling higher and live longer. Kidney transplantation is a procedure that places a healthy kidney from another person into your body. This one new kidney takes over the work of your two failed kidneys. Kidney transplantation or renal transplantation is the organ transplant of a kidney into a patient with end-stage renal disease.
Track 23: Dialysis and Renal Care
Renal dialysis is a procedure that is a supernumerary for many normal functions of the kidney. Dialysis consents people with kidney failure a chance to live productive lives. There are primarily two types of dialysis: Haemodialysis and Peritoneal dialysis. Haemodialysis is the process of purification of the blood of a person whose kidneys does not function properly. Peritoneal dialysis customs the lining of the abdomen (peritoneum) and a cleaning solution (dialysate) used to clean blood.
Track 24: Renal Health & Cure
Renal health is essential for the human body to function properly. Removal of wastes from the body is done by the renal system, without which other body functions get affected. Treatment options vary, depending on the cause. But kidney damage can continue to worsen even when an underlying condition, such as high blood pressure, has been controlled. Treatments may include: Medications to High blood pressure, lower cholesterol levels, treat anaemia etc. Treatment for end-stage kidney disease includes Dialysis and Kidney transplantation.
Track 25: Female infertility
Female infertility refers to infertility in women and it occurs when a woman is unable to conceive after 12 months of regular, unprotected sexual intercourse. A menstrual cycle that's too long (35 days or more), too short (less than 21 days), irregular or absent can mean that female lack ovulating. Some causes of infertility in women are treatable; for those that are not, assisted conception, surrogacy or adoption could be considered as alternative ways to start a family.
Track 26: Male Reproductive Cancers and Infertility
Reproductive cancers in men can be found in the penis, testicles, and prostate gland and it causes risk to the male population. Prostate cancer is the most common no skin cancer in the United States, Testicular cancer is the most common solid malignancy affecting men ages 15 to 35, and Penile cancer comprises 20% of cancers in men in Africa, Asia, and South America.
Track 27: Bladder Cancer
Kidney forms the urine which is stored in the bladder. Abnormal growth of cells in the bladder leads to formation of tumour which is termed as Bladder Cancer. This session is dedicated to discussing the unknown causes of Bladder cancer and to enhance knowledge. The Causes of bladder cancer include: Smoking and other tobacco use, Exposure to chemicals, past radiation exposure, chronic irritation of the lining of the bladder and Parasitic infections.
Track 28: Prostate Cancer
A slow progressing form of cancer in men is the Prostate cancer. It is when a tumour develops in the Prostate gland of men. With most causes unknown, Prostate cancer risk increases with age and family history of Prostate cancer. Prostate cancer that's more advanced may cause signs and symptoms such as: Trouble urinating, decreased force in the stream of urine, Blood in semen, Discomfort in the pelvic area, Bone pain, Erectile dysfunction etc. The PSA blood test checks the amount of prostate-specific antigen that’s in your blood. If the levels are high, this could mean you have prostate cancer.
Track 29: Surgical treatment of intermediate risk prostate cancer
Surgery involves the removal of the prostate and some surrounding healthy tissue during an operation. The type of surgery depends on the stage of the disease, the man’s overall health, and other factors. Surgical options include: Radical (open) prostatectomy, Robotic or laparoscopic prostatectomy and bilateral orchiectomy. Radiation therapy is the use of high-energy rays to destroy cancer cells. A doctor who specializes in giving radiation therapy to treat cancer is called a radiation oncologist. External-beam radiation therapy, Brachytherapy, Intensity-modulated radiation therapy (IMRT) and Proton therapy are also used to destroy the cancer cells by the insertion of radioactive implants directly into the tissue.
Track 30: Advancements in Urology
The world of medicine keeps changing. New diseases erupt every day. It is essential to keep in pace with the recent advancements. Hence this session is dedicated to discussing and debates the recent advancements in the field of Urology.
According to the new market research report, Gastrointestinal Diseases Market, by Drug Category - Global Income, Patterns, Development, Share, Size and Estimate to 2022", the gastrointestinal infections advertise was developed from USD 19.79 billion in 2016 and at that point reach USD 20.68 billion by 2022, developing at a CAGR of 2.3% amid estimate period. The global gastrointestinal market report offers the in-depth examination of the revenue, market share, major market segments, distinctive geographic districts, key players, premium patterns and estimates to 2022. It moreover centres on the key drivers and too on opportunities in this market.
Scope and Importance
The main aim of the market research is to increase the awareness of gastrointestinal disorders among people and to identify the gastrointestinal market landscape as well as important advancements. Infectious gastrointestinal diseases are also becoming increasingly difficult to diagnose due to the increasing dissemination of among microorganisms and the emergence of the so-called 'superbugs'. Taking into consideration these problems, the need for novel therapeutics is essential.
This study analyses various therapeutic options currently on the market as well as potential products and classes of products that are likely to have a significant impact on the future for the prescription as well as the over the counter (OTC) gastrointestinal drug markets. The gastrointestinal market is one of the key therapeutic areas most significantly affected by the generic erosion of blockbusters
Global Market Value
According to Market research the Global Gastrointestinal Drugs Market Revenue by Region in 2016, North America was the highest by getting the revenue of 17,288 US Dollar Million, while the Middle East and Africa Continent was having least generation of revenue. The demand for ambulatory surgery centre is high in Europe and Asia Pacific owing to the government initiatives to overcome the shortage of medical facilities in remote areas of developing countries such as India and China.
Fig: Global ambulatory Surgery Centres Market share (%) by, 2023
The North America ambulatory surgery centre market is expected to witness significant growth rate in future due to the enough outpatient surgery centres and government regulations governing the preference for outpatient surgery centres in order to expand the reach of medical facilities.
Global Gastrointestinal Endoscopic Devices Market
The global gastrointestinal endoscopic devices market accounted for approximately USD 5.6 Billion in 2015 and is expected to reach approximately USD 8.5 Billion by 2021, growing at a CAGR of around 7.0% between 2016 and 2021.
Source: Zion Market Research | Global Gastrointestinal Endoscopic Devices Market
Technological Innovation in the GI Endoscope Market
New Technological advancements will continue to precede the gastrointestinal endoscope market. Recent generations of endoscopes will continue to progressively promote on visualization and detection technologies. It is projected to exceed $1.7 billion by 2020.Furthermore; increasing adoption of minimally invasive procedures is propelling the growth of gastrointestinal stents market. These devices are becoming the preferred choice for the management of various gastrointestinal diseases due to certain benefits it provides over conventional products in terms of reduced blood loss, lesser chances of infection, shorter hospital stay, and quick recovery.
Source: U.S. Global gastrointestinal stents market
The U.S. global gastrointestinal stents market is growing at a steady rate and is primarily driven by factors such as growing aging population, changing lifestyles, & intake of unhealthy foods that increases the incidence of digestive tract problems. The market leaders in gastrointestinal stents market include Boston Scientific & Cook Medical. The rising GI Cancer demand such as colorectal cancer, oesophageal cancer, gallbladder cancer, pancreatic cancer, and rectal cancer have increased the demand for gastrointestinal stents in the market.
UROLOGICAL DEVICES MARKET SHARE INSIGHTS
The global urology devices market was valued at USD 30,967.15 million in 2018 and is estimated to be valued at USD 44,804.97 million in 2024, witnessing a CAGR of 6.35%. The key factors propelling the market growth include high incidence of urologic conditions, rising geriatric population, and technological advancements. In the U.S. urology market, the demand side of the market continues to undergo consolidation, with hospitals acquiring outpatient facilities and expanding the reach of the group purchasing organizations (GPOs), coupled with the reimbursement cuts across the urology space, average selling prices are expected to remain under significant pressure, negatively impacting the future growth of the market.
Urology Devices Market to Rise At 7.1% CAGR by 2023, according to Urology Devices Market 2019 Global Analysis To 2023 report published by Market Research Future. Urology Devices Industry report analyses Market for Urology Devices Types (Dialysis Equipment, Urinary Stone Treatment Devices, Endoscopy Devices, Benign Prostatic Hyperplasia Treatment Devices, Urinary Incontinence & Pelvic Organ Prolapsed), By Technology (Minimally Invasive Surgery And Robotic Surgery), By Applications (Benign Prostatic Hyperplasia, Prostate Cancer, Urinary Stones, Urinary Incontinence), By End Users (Hospitals, Ambulatory Services And Others), region with Forecast To 2023.
Since NeoTract launched UroLift®, an implant for the treatment of BPH, in the U.S. in 2013 and in Europe in 2010, the device has been rapidly adopted by urologists, following the trend from other regions where it is available, such as Canada, Australia and more. The UroLift® procedure is minimally invasive and can be performed in a relatively short amount of time, making it an attractive treatment option for BPH. In 2017, NeoTract was acquired by Teleflex, which is expected to further drive adoption of UroLift® by leveraging the large presence and sales distribution network of Teleflex. Globally, strong competition is found through top players, such as Teleflex, Hollister, Boston Scientific, BARD, Karl Storz, Cook Medical, LABORIE, Olympus and others.
In the U.S. urology market, the leading competitor is Boston Scientific. The company holds the leading positions in the stone management device market, BPH treatment device market and erectile dysfunction market. BARD is the second-leading competitor. The company also holds the leading position in the urinary incontinence device market, solely attributed to its dominant position in the urinary catheter market. Coloplast was the third-leading competitor. The company currently stands as the second-leading positions in the urinary incontinence device market and erectile dysfunction device market.
In both the Indian and Japanese urology markets, Varian Medical Systems was the leading competitor in the total urological device markets. The company was only involved in the external beam radiation therapy segment. Among these urological device market segments, the EBRT segment was the largest, which contributed to the company’s large share of the total prostate cancer treatment market.
Source: Urology Market Analysis
Throughout this research series, I Data has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are:
- United States
- Europe (15 countries including: Germany, France, U.K., Italy, Spain, Benelux (Belgium, Netherlands and Luxembourg), Scandinavia (Denmark, Finland, Norway and Sweden) Austria, Switzerland and Portugal)
Major Urology Devices Companies covered in the market report include:
- American Medical Systems (U.S.)
- Boston Scientific (U.K.)
- Olympus (U.S.)
- Coloplast (Denmark)
- Cook Medical (U.S.)
- C.R. Bard (U.S.)
- Endo Health Solutions Inc. (U.S),
- Fresenius Medical Care (Germany)
- Baxter (US),
- Richard Wolf (US),
- KARL STORZ (Germany)
- Medtronic (US),
- Dornier MedTech (Germany),
- Prometheus Group (US),
- Medi-Globe (US),
- Intuitive Surgical (US)
- Merit Medical Systems (US)
- Siemens Healthcare (Germany)
- Stryker (US)
- ROCAMED (France)
- Medica (Italy)
- NOVAmedtek (Turkey)
- SRS Medical Systems (US)
- ProSurg (US)
- Albyn Medical (UK)
- EMD Medical Technologies (Canada)
- Biolitec (Germany)
Are some of the prominent players at the forefront of competition in the global urology devices market and are profiled in MRFR Analysis.
Global Urology Devices Market Segments:
- By Types (Dialysis Equipment, Urinary Stone Treatment Devices, Endoscopy Devices, Benign Prostatic Hyperplasia Treatment Devices, Urinary Incontinence & Pelvic Organ Prolapsed).
- By Technology (Minimally Invasive Surgery and Robotic Surgery), By Applications (Benign Prostatic Hyperplasia, Prostate Cancer, Urinary Stones, Urinary Incontinence).
- By End Users (Hospitals, Ambulatory Services and Others) – Global Forecast Till 2023
With people from around the globe concentrated on finding out around most recent expository and treatment strategy of distinctive gastrointestinal ailments and hepatology. This is your best chance to accomplish the biggest cluster of individuals from the world. From the conference and discourse of the famous individuals of gastroenterology conference 2019, you can revive your insight approximately current circumstance of gastroenterology and get the name and acknowledge at this online event.
Major Gastroenterology Associations around the Globe
- American Gastroenterological Association
- American Urological Association
- The Australian and New Zealand Gastric and Oesophageal Surgery Association (ANZGOSA)
- European Association of Urology
- Asian Pacific Association of Gastroenterology (APAGE)
- British Association of Urological Surgeons
- Gastroenterohepatology Association of Montenegro - GAM
- Prostate Cancer Foundation
- The Japanese Gastroenterological Association (JGA)
- ZERO—The End of Prostate Cancer
- European Association for Gastroenterology, Endoscopy and Nutrition
- Ukrainian Association of Endoscopy
- Canadian Association of Gastroenterology (CAG)
- IGA - Israel Gastroenterology Association
- Bulgarian Association of Surgeons and Gastroenterologists
Major Gastroenterology Societies around the Globe
- American Society for Gastrointestinal Endoscopy
- Society of Academic Urologists
- British society of Gastroenterology
- European Society for Paediatric Urology: ESPU
- Gastroenterological Society of Australia
- Urological Association of Asia
- Hong Kong Society of Gastroenterology
- The Society for Basic Urologic Research
- Emirates Gastroenterology & Hepatology Society
- International Society of Urological Pathology: ISUP
- European society of Neuogastroenterology & Motility
- International Continence Society
- European Society of Gastrointestinal Endoscopy (ESGE)
- Société Internationale d'Urologie
- Russian Society for Digestive Endoscopy
- World Federation of Societies for Paediatric Urology
- Japanese Society of Gastroenterology
- Society of Urologic Nurses and Associates
- Belgian Society of Gastrointestinal Endoscopy
Major Hospitals Associated with Gastroenterology in worldwide:
- Barnes-Jewish Hospital/Washington University
- Cedars-Sinai Medical Centre
- Clarian Health
- Cleveland Clinic
- Duke University Hospital
- Hospital of the University of Pennsylvania
- Johns Hopkins Hospital
- Keck Medical Center of USC
- Massachusetts General Hospital
- Mayo Clinic
- Mount Sinai Hospital
- New York-Presbyterian University Hospital of Columbia and Cornell
- Ronald Reagan UCLA Medical Centre
- UCSF Medical Center
- University of Chicago Medical Centre
- University of Michigan Hospitals and Health Centers
- University of Texas M.D. Anderson Cancer Centre
- UPMC-University of Pittsburgh Medical Centre
- Fundamentals in Gastroenterology
- Advancements in Gastroenterology
- Pediatric Gastroenterology
- Gastrointestinal Surgery
- Cellular and Molecular Gastroenterology
- Gastrointestinal Disorders and Symptoms
- Gut Microbiome
- Diagnostic and Therapeutic Innovations in Gastroenterology
- Nutrition, Obesity and Eating Disorders
- Gastrointestinal Neoplasms
- Gastrointestinal Transplantation
- Urinary Tract Infection
- Urinary Retention
- Urinary Tract Imaging
- Urology Robotic Surgery
- Kidney Stones
- Kidney Cancer
- Kidney Transplantation
- Dialysis and Renal Care
- Renal Health & cure
- Female infertility
- Male Reproductive Cancers and Infertility
- Bladder Cancer
- Prostate Cancer
- Surgical treatment of intermediate risk prostate cancer
- Advancements in Urology
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
|Conference Date||August 17-18, 2020|
|Sponsors & Exhibitors||
|Speaker Opportunity Closed|
|Poster Opportunity Closed||Click Here to View|
All accepted abstracts will be published in respective Our International Journals.
- Journal of Gastrointestinal & Digestive System
- Hepatology and Pancreatic Science Open Access
- Clinical Gastroenterology Journal Open Access
Abstracts will be provided with Digital Object Identifier by